DOCSLIB.ORG

NHS England Board Members

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
NHS England Board Members BOARD OF DIRECTORS - REGISTER OF INTEREST NHS England and NHS Improvement are committed to openness and transparency in its work and decision making. As part of that commitment, we maintain and publish this Register of Interests which draws together Declarations of Interest made by members of the Board of Directors. In addition, at the commencement of each Board meeting, members of the Board are required to declare any interests. NHS England Board Members Lord David Prior Chair Deputy Chairman Lazards Director Genomics England Board Member WWG Advisory Board, University of Warwick Chairman Quality by Randomisation Limited Currently invested in - Mindful Vidya Baccuico Family interest Son is a Junior doctor Niece is a General Practitioner Sir Simon Stevens Chief Executive Non-Executive Director Commonwealth Fund Family interest Spouse is an unpaid member of the Independent Monitoring Board of Feltham Young Offenders Institution David Roberts Vice Chair Chairman Nationwide Building Society Associate Non-Executive NHS Improvement Director Chairman Beazley Furlonge Ltd Chairman Beazley Plc Non-Executive Director Campion Wilcocks Ltd Member, Strategy Board Henley Business School, University of Reading Advisory Board Member The Mentoring Foundation Daughter Junior Doctor Sister-in-law Salaried GP in Liverpool Niece Senior Midwife in Leeds Niece Senior Nurse in Manchester Niece Works in CCG in Leeds Cousin Works in CCG in Cheshire Chairman Beazley Furlonge Ltd Chairman Beazley Plc Non-Executive Director Campion Wilcocks Ltd Member, Strategy Board Henley Business School, University of Reading Mike Coupe Non-Executive Director Chairman Oak Furniture Ltd Lord Ara Darzi Non-Executive Director President British Science Association (non remunerated) Board Member Evelo Biosciences Director Ara Darzi London Ltd (UK private practice) Director Prova Health Ltd Director and Chair Global Health Education Group Limited Director and Chair Faro Ventures Limited Chair Accelerated Access Collaborative Paul Hamlyn Chair of Surgery Institute of Global Health Innovation, Imperial College, and Director London Consultant Surgeon Imperial College Healthcare NHS Trust and The Royal Marsden Foundation Trust Executive Chair World Innovation Summit for Health, Qatar Foundation. (non remunerated) Member J-Clinic Advisory Board (non remunerated) Trustee Meningitis Trust Trustee The Lord Leonard and Lady Estelle Wolfson of Marylebone Charitable Trust for Preventative Medicine Trustee Rangoon General Hospital Reinvigoration Charitable Trust Trustee Health, Innovation and Systems Reform Charity Advisory Board Member N Sethia Foundation Vice Chair Sidra Medical and Research Centre, Qatar Trustee Helen Hamlyn Trust Member Advisory Board, Qatar Foundation Member International Advisory Panel, Hamad Healthcare Quality Institute, Qatar Trustee National Competitiveness Foundation of Armenia (on the invitation of the Prime Minister of Armenia) Chair Aurora Prize Selection Committee, Armenia Chair Health Security Initiative – Flagship Pioneering UK Ltd Founding Share Holder Dosium Holding Ltd Member Life Sciences Council Member Advisory Committee, Multi-Scale Medical Robotics Centre Hong Kong Member Recovery, Resilience and Growth Oversight Group, Department of Health and Social Care Susan Kilsby Non-Executive Director Non-Executive Director Diageo plc Chairman Fortune Brands Home and Security Non-Executive Director BHP Limited and BHP plc Non-Executive Director Unilever plc Senior Visiting Fellow Cass Business School Chairman M&A Research Centre Cass Business School Senior Industry Advisor Star Mountain Capital Board of Advisors Diligent Institute Mentor Chairman Mentors International Board of Advisors Gordon A Rich Foundation Member Wellesley College Business Leadership Council Member Wellesley College President’s Advisory council Senior Advisor Siddhi Acquisition Shareholder Impact Partners, Florida USA Shareholder Takeda Pharmaceutical Company Shareholder Roche Holding AG Family member NHS Consultant, Newcastle Jeremy Townsend Non-Executive Director Non-Executive Director Wm Morrisons plc Non-Executive Director PZ Cussons plc Trustee Parkrun Global Daughter Doctor practising in Harrogate Daughter Doctor practising in St Helier Two Nephews Studying medicine at St Andrew’s University Spouse Trustee of St Christophers - Charity Laura Wade-Gery Non-Executive Director Chair NHS Digital Non-Executive Director British Land plc Trustee Britten Pears Arts – formally known as Snape Maltings Chair Snape Maltings Trading Limited, subsidiary of Britten Pears Arts Shareholder Tesco, Marks & Spencer, British Land NHS Improvement Board Members Dido Harding Chair Interim Chair National Institute for Health Protection (which includes the Test, Track and Trace programme) Deputy Chair and Remco Bank of England Chair Director of the Board Jockey Club Senior Independent Director MindGym Plc Trustee MyArgo Member of Advisory Board The Fore Whip Conservative Party in the House of Lords Family member Member of Parliament for Weston-Super-Mare Sir Andrew Morris Vice Chair Deputy Chair Disability Imitative (charity based in Camberley) Associate Non Executive Health Education England Director Associate Value Circle Family member Employed by NHS Lord Carter of Coles Non-Executive Director Chair Primary Group Chair Glenholme Group Chair The Freehold Corporation Chair Health Services Laboratories Director/Shareholder JKHC Ltd Rakesh Kapoor Non-Executive Director Director 12 Flags International Ltd Director 12 Flags Capital Ltd Director Dolby Partners Ltd Director Dolby Investments Ltd Family Member Founder/CIO of Silver Mount Capital Ltd Munir Pirmohamed Non-Executive Director Chair Commission on Human Medicines (CHM) Chair COVID 19 Vaccine Benefit Risk Expert Working Group Committee Member COVID Expert Working Group Committee Member UK COVID Therapeutics Advisory Panel (UKRI) Committee Member DHSC Covid Immunology Group Director HDRUK North Chair David Weatherall Chair of Medicine and NHS Chair of Pharmacogenetics and Honorary Consultant Physician - University of Liverpool and Liverpool University Hospitals Foundation NHS Trust President British Pharmacological Society Chair MRC – UK Research & Innovation Panel Member REF2021 – Research England Patron SJS Awareness UK Charity Patron Genomic Medical Foundation UK Fellow Royal College of Physicians of London Fellow Royal College of Physicians of Edinburgh Fellow Academy of Medical Sciences Honorary Fellow Faculty of Pharmaceutical Medicine Fellow Royal Society of Biology Member Association of Physicians Medical Trustee British Heart Foundation Vice Chair Qatar Precision Medical Initative Panel Member Scientific Board, Our Future Health Academic Research Grants Research funding paid to the University of Liverpool from MRC, NIHR, Health Education England and EU Commission. Partnership funding for the MRC Clinical Pharmacology Training Scheme (co-funded by MRC and Roche, UCB, Eli Lilly and Novartis). PhD studentship jointly funded by EPSRC and Astra-Zeneca. Grant funding from Vistagen Therapeutics Family Member Medical student at Newcastle University Wol Kolade Non-Executive Director Livingbridge is a Private Equity House who invest and will continue to invest in Health and Social Care business Currently invested in: Helping Hands https://www.helpinghandshomecare.co.uk/ Vanguard http://www.vanguardhs.com/ Chairman Guys & St Thomas’ Charity Family Member Consultant Haematologist at Blackpool Victoria Hospital Sir David Behan Associate Non-Executive Director Chair Health Education England Chair The Advisory Board, CERA Care Ltd Chair Programme Advisory Group, ESRC and Health Foundation UK Centre for Evidence Implementation in Adult Social Care Chair Advisory group for a research programme in innovation in adult social care, Care Policy and Evaluation Centre, London School of Economics Advisory Group Member (Social Care Workstream), IPPR Ambassador Health Foundation to the Sciana International Leadership Development Programme for 2020 and 2021 and 2022 Advisory Group Member NIHR funded, LSE delivered research programme into the Models of Support for Moderate Needs in Older People (MSMOP) Family Member Director for Positive Behavioural Support UK Joint Board Members of NHS England and NHS Improvement Julian Kelly Chief Financial Officer Fellow Policy Leaders Fellowship Family Member Consultant Paediatrician Two Family Members Oxford Vaccine Research Group Ruth May Chief Nursing Officer Family Member Chairman at Mid and South Essex Foundation Trust Professor Stephen Powis National Medical Director Member American Society of Nephrology Member American Society of Transplant Physicians Member Association of Physicians Member British Society for Immunology Member British Transplantation Society Member European Dialysis & Transplantation Association Member Faculty of Medical Leadership and Management Fellow Royal College of Physicians of London Fellow Royal Society of Medicine Hon Fellowship in Medicine Royal College of Physicians and Surgeons of Glasgow Member International Society for Nephrology Member Renal Association Member Royal Society of Medicine Member The Transplantation Society Member British Medical Association Hon Professor University College London Family Member Completed a NHS Graduate training scheme and now employed within NHS Family Member Completed a NHS Graduate training scheme and now employed within NHS Amanda Pritchard Chief Operating Officer On secondment to NHS Substantively employed by Guys and St Thomas’ NHS England/NHS Improvement
Load more

Recommended publications
  • Burton Role Name Brief Biography Panel Chair Ruth May Dr
    Burton Role Name Brief Biography Panel Chair Ruth May Dr Ruth May is NHS England Regional Director of Nursing for Midlands and East. Her previous roles include Chief Nurse for NHS Midlands and East and Chief Nurse for NHS East of England. Ruth has a theatre nursing background and more than 20 years experience of working in the NHS. Patient/Public Representative Norma Armston Norma Armston has a wide range of experience as a patient/carer representative at both local and national level. She has been involved in reviewing cancer services and was a lay assessor in the Clinical Commissioning Group authorisation process. Patient/Public Representative Alan Keys Alan Keys is Lay Member for PPI on the board of High Weald Lewes Havens CCG. He is also a member of various other groups including the British Heart Foundation Prevention and Care Reference. Patient/Public Representative Leon Pollock Leon Pollock is a management consultant with over 30 years experience during which he has assisted more than 250 organisations, including 20 NHS trusts. He is Lay Adviser for Health Education West Midlands and Lay Assessor for the NHS Commissioning Board. Doctor Balraj Appedou Balraj Appedou is a consultant in anaesthesia and intensive care medicine at the Peterborough and Stamford Hospitals NHS Foundation Trust. Balraj is currently Lead for Clinical Governance in the Theatres Anaesthesia and Critical Care Medicine Directorate. Balraj has also been the Patient Safety Champion in the Trust. Doctor Mike Lambert Mr. Mike Lambert is a consultant at Norfolk and Norwich University Hospital and Honorary Senior Lecturer at Norwich Medical School.
    [Show full text]
  • Board of Directors - Open
    Board of Directors - Open Date: 12 August 2020 Item Ref: 05 TITLE OF PAPER Chief Executive’s Report TO BE PRESENTED BY Jan Ditheridge ACTION REQUIRED The Board are asked to consider the impact and opportunity of the letter from Sir Simon Stevens and Amanda Pritchard regarding the third phase of the NHS response to CoVid on our strategic priorities and risks. The Board are asked to approve the recommendation re Executive lead for Inequalities. The Board are asked if there are any other issues that arise from the letter from Sir Simon Stevens and Amanda Pritchard we should consider. The Board are asked to consider the National Guardian Freedom to Speak Up Index Report 2020 and if they feel confident where and how we are addressing the issues it raises for us. The Board are asked to consider the NHS People Plan 2020/21, and where we may want the People Committee to focus attentions as an organisation, given our risks and challenges and as a contributor to our health and care system. The Board are asked to consider the direction of travel of the Accountable Care Partnership; and to understand the key priorities and how they relate to our own transformation programme. The Board are asked to acknowledge the Board role changes, consider any opportunities or risks within the changes and join me in thanking individuals for their contributions and wish them well where they have changed or moved into different roles. OUTCOME To update the Board on key policies, issues and events and to stimulate debate regarding potential impact on our strategy and levels of assurance.
    [Show full text]
  • UNDERSTANDING the NEW NHS a Guide for Everyone Working and Training Within the NHS 2 Contents 3
    England UNDERSTANDING THE NEW NHS A guide for everyone working and training within the NHS 2 Contents 3 NHS ENGLAND INFORMATION READER BOX Introduction 4 Directorate ◆ The NHS belongs to us all Medical Operations Patients and information Nursing Policy Commissioning development Foreword (Sir Bruce Keogh) 5 Finance Human resources NHS values 6 Publications Gateway Reference: 01486 ◆ NHS values and the NHS Constitution Document purpose Resources ◆ An overview of the Health and Social Care Act 2012 Document name Understanding The New NHS Structure of the NHS in England 8 Author NHS England ◆ The structure of the NHS in England Publication date 26 June 2014 ◆ Finance in the NHS: your questions answered Target audience Running the NHS 12 ◆ Commissioning in the NHS Additional circulation Clinicians working and training within the NHS, allied ◆ Delivering NHS services list health professionals, GPs ◆ Health and wellbeing in the NHS Description An updated guide on the structure and function of Monitoring the NHS 17 the NHS, taking into account the changes of the Health and Social Care Act 2012 ◆ Lessons learned and taking responsibility ◆ Regulation and monitoring in the NHS Action required None Contact details for Dr Felicity Taylor Working in the NHS 20 further information National Medical Director's Clinical ◆ Better training, better care Fellow, Medical Directorate Skipton House NHS leadership 21 80 London Road SE1 6LH ◆ Leading healthcare excellence www.england.nhs.uk/nhsguide/ Quality and innovation in the NHS 22 ◆ High-quality care for all Document status This is a controlled document. While this document may be printed, the The NHS in the United Kingdom 24 electronic version posted on the intranet is the controlled copy.
    [Show full text]
  • NHS Long Term Plan (Pdf)
    Long-Term Plan Long-Term Plan Long-Term The NHS Long Term Plan Plan Long-Term Plan #NHSLongTermPlan www.longtermplan.nhs.uk [email protected] www.longtermplan.nhs.uk #NHSLongTermPlan January 2019 The NHS Long Term Plan 3 Contents THE NHS LONG TERM PLAN – OVERVIEW AND SUMMARY 6 CHAPTER 1: A NEW SERVICE MODEL FOR THE 21ST CENTURY 11 1. We will boost ‘out-of-hospital’ care, and finally dissolve the historic divide 13 between primary and community health services A new NHS offer of urgent community response and recovery support 14 Primary care networks of local GP practices and community teams 14 Guaranteed NHS support to people living in care homes 15 Supporting people to age well 16 2. The NHS will reduce pressure on emergency hospital services 18 Pre-hospital urgent care 19 Reforms to hospital emergency care – Same Day Emergency Care 21 Cutting delays in patients being able to go home 23 3. People will get more control over their own health and more personalised 24 care when they need it 4. Digitally-enabled primary and outpatient care will go mainstream 25 across the NHS 5. Local NHS organisations will increasingly focus on population health – 29 moving to Integrated Care Systems everywhere CHAPTER 2: MORE NHS ACTION ON PREVENTION AND HEALTH INEQUALITIES 33 Smoking 34 Obesity 36 Alcohol 38 Air pollution 38 Antimicrobial resistance 39 Stronger NHS action on health inequalities 39 CHAPTER 3: FURTHER PROGRESS ON CARE QUALITY AND OUTCOMES 44 A strong start in life for children and young people 45 Maternity and neonatal services 46 Children
    [Show full text]
  • South Central Strategic Health Authority 2012-13 Annual Report and Accounts
    South Central Strategic Health Authority 2012-13 Annual Report and Accounts You may re-use the text of this document (not including logos) free of charge in any format or medium, under the terms of the Open Government Licence. To view this licence, visit www.nationalarchives.gov.uk/doc/open-government-licence/ © Crown copyright Published to gov.uk, in PDF format only. www.gov.uk/dh 2 South Central Strategic Health Authority 2012-13 Annual Report and Accounts 3 South Central Strategic Health Authority Annual Report 2012/13 The three Strategic Health Authorities (SHAs) in the South of England – South Central, South East Coast and South West – merged to form one SHA for the South of England in October 2011. However, three versions of the annual report have been produced because each individual SHA is a statutory body and therefore required to produce an annual report. Each report should be read in conjunction with the SHA handover documents: ● Maintaining and improving quality during transition: handover document ● Operational Handover and Closedown Report Chairman and Chief Executive’s Foreword This year has been a challenging and busy time for the NHS and the South of England has been no exception. As new NHS structures have emerged, staff have worked hard to set up new systems and develop new working relationships while continuing to deliver the demands of their current roles without interruption. All parts of the NHS across the South of England have worked together to sustain and improve the quality of services delivered and to leave a strong legacy so that all the new Chairman Dr Geoff Harris OBE Clinical Commissioning Groups will start without debt.
    [Show full text]
  • Letter from Simon Stevens to Matt Hancock on 18 November 2019
    Skipton House 80 London Road To: The Rt Hon. Matt Hancock M.P. London SE1 6LH Secretary of State for Health and Social Care By email 18 November 2019 Dear Secretary of State, As you know, there is sustained concern across the NHS about the operational impact of pensions tax penalties on the availability of clinical staff. Staffing constraints and the nature of clinical contracts mean the NHS is arguably much more exposed to these impacts than other public services. While the various in-year flexibilities already announced are helpful, they are clearly not sufficient to prevent large numbers of senior clinicians reducing their sessional commitments, including in A&E departments, general practice and undertaking waiting list operations. The Academy of Medical Royal Colleges provided further evidence of this in their letter to you and the Chancellor dated 4 November 2019, which I attach. Given the deferral of the Budget and the calling of an election, it is now clear that a substantive answer to the tapered annual allowance issue is unlikely to be forthcoming until the new tax year, from April 2020. In the meantime there is an urgent operational requirement to remediate further the situation, so as to try and remove barriers to needed clinical staffing over the winter period. To that end, as you know, we have been working with your officials and HMT on an in-year mitigation. This will involve a commitment to make payments to certain clinical staff outside of the NHS pension schemes to restore the value of their pension benefits package, if they have elected to use the “Scheme Pays” facility to settle an annual allowance tax charge arising from of their pension saving in the NHS schemes in 2019/20.
    [Show full text]
  • The Healthy NHS Board Principles for Good Governance
    The Healthy NHS Board Principles for Good Governance Foreword The Healthy NHS Board We are delighted to introduce The Healthy NHS Board: principles for good governance, and would like to encourage boards across the system to make use of this guide as they seek to address the challenges of improving quality for patients. The National Leadership Council (NLC) has led this work to bring the latest research, evidence and thinking together. High Quality Care For All made it clear what the NHS is here to do – to improve the health of our population and to make quality the organising principle of the service. Boards must put quality at the heart of all they do. This guide, and the online resources that accompany it, support boards in exercising that responsibility. When we talk about quality, we mean patient safety, effectiveness of care and patient experience. Assuring these three elements of quality for patients should be central to the work of everyone in the NHS. The NHS is putting in place levers and incentives to improve quality, including linking the payment system more closely with patients’ experiences, as well as strengthening the regulatory system to safeguard quality and safety. As these changes take shape, it is timely to refresh guidance to NHS boards to support them as they go forward. In a system as large and complex as the NHS, it is helpful to have a common understanding of what we mean by good governance and what it takes to be a high-performing board. The NHS has had a decade of growth but is facing the challenge of managing with less in the future.
    [Show full text]
  • TRUST BOARD1 Thursday, 30 January 2014 1500 Sir William Well’S Atrium, Royal Free Hospital, Ground Floor Dominic Dodd, Chairman ITEM LEAD PAPER 1
    TRUST BOARD1 Thursday, 30 January 2014 1500 Sir William Well’s Atrium, Royal Free Hospital, ground floor Dominic Dodd, Chairman ITEM LEAD PAPER 1. ADMINISTRATIVE ITEMS 1.1 Apologies for absence ‐ D Dodd, S Payne 1.2 Minutes of meeting held 24 October 2013 D Bernstein 1.1 1.3 Matters arising report D Bernstein 1.2 1.4 Record of items discussed at Part II board meetings on 24 October, 28 D Bernstein 1.3 November, 19 December 2013 and 8 January 2014 1.5 Patient voices D Oakley v 2. ORGANISATIONAL AGENDA 2.1 Nurse staffing on wards (Francis report) D Sanders 2.1 2.2 Declaration of compliance – mixed sex wards D Sanders 2.2 2.3 DIPC report D Sanders 2.3 2.4 Annual equality information report D Sanders 2.4 2.5 Quarterly medical revalidation report S Powis 2.5 2.6 Quality accounts 2013/14 – development timetable and sign off process S Powis 2.6 3. OPERATIONAL AGENDA 3.1 Chairman’s report D Bernstein 3.1 3.2 Chief executive’s report D Sloman 3.2 3.3 Trust performance report D Sloman 3.3 3.4 Financial performance report C Clarke 3.4 Governance and Regulation: reports from board committees 3.5 Finance and performance committee report D Bernstein 3.5 3.6 Strategy and investment committee report D Bernstein 3.6 3.7 Risk, governance and regulation committee report S Ainger 3.7 3.8 Audit committee report D Oakley 3.8 3.9 Clinical performance committee report A Schapira 3.9 3.10 User experience committee report J Owen 3.10 4.
    [Show full text]
  • Review Into the Quality of Care and Treatment Provided by 14 Hospital Trusts in England: Overview Report
    Review into the quality of care and treatment provided by 14 hospital trusts in England: overview report Professor Sir Bruce Keogh KBE 16 July 2013 Contents Letter to the Secretary of State 3 1 An achievable ambition for improvement 7 2 Introduction 13 3 Key findings from the review 16 4 Areas for improvement in the 14 trusts 18 4.1 Patient experience 18 4.2 Safety 20 4.3 Workforce 21 4.4 Clinical and operational effectiveness 23 4.5 Leadership and governance 25 5 The capacity for improvement and requirement for external support 28 6 Learning from the review process 31 Annex A Summary of findings and actions for the 14 trusts 35 Annex B Resources required for the reviews 49 Annex C National advisory group members 50 Annex D Rapid responsive review team members 52 Annex E Sources used for compilation of data packs 60 2 Letter to the Secretary of State Dear Secretary of State for Health, In February you and the Prime Minister asked me to conduct a review into the quality of care and treatment provided by hospital trusts with persistently high mortality rates. Your rationale was that high mortality rates at Mid Staffordshire NHS Foundation Trust were associated with failures in all three dimensions of quality - clinical effectiveness, patient experience, and safety - as well as failures in professionalism, leadership and governance. I selected 14 trusts for this review on the basis that they had been outliers for the last two consecutive years on either the Summary Hospital-Level Mortality Index (SHMI) or the Hospital Standardised Mortality Ratio (HSMR).
    [Show full text]
  • The NHS Internal Market
    The NHS Internal Market Edited by Eleanor MacKillop, Sally Sheard, Philip Begley and Michael Lambert Department of Public Health and Policy University of Liverpool Department of Public Health and Policy, University of Liverpool. All rights reserved. This material is made available for personal research and study only. We give permission for this file to be downloaded for such personal use. For reproduction and further distribution of all or part of this file, permission must be sought with the copyright holder. Published by: Department of Public Health and Policy, University of Liverpool, 2018. ISBN: 978-1-9999209-1-3 2 The NHS Internal Market The Transcript of a Witness Seminar held at the University of Liverpool in London, UK, on 5 December 2017 Acknowledgements: The convenors would like to thank the witnesses for their involvement, the audience, and the staff at the University of Liverpool in London. They would also like to thank Ubiqus for transcribing the event. Photographs: Department of Public Health and Policy, University of Liverpool. 3 Contents Instructions for citation ................................................................................................................... 5 Contributors .................................................................................................................................... 6 Introduction ..................................................................................................................................... 8 Areas for discussion .....................................................................................................................
    [Show full text]
  • Review Into the Quality of Care & Treatment Provided by 14 Hospital
    North Cumbria University Hospitals NHS Trust Review into the Quality of Care & Treatment provided by 14 Hospital Trusts in England Key Findings and Action Plan following Risk Summit July 2013 Contents 1. Overview 3 2. Summary of Review Findings and Trust Response 6 3. Risk Summit Action Plan 15 Appendices 19 Appendix I: Risk Summit Attendees 20 2 1. Overview A Risk Summit was held on 6 June 2013 to discuss the findings and actions of the Rapid Responsive Review of North Cumbria University Hospitals NHS Trust. This report provides a summary of the discussion held, including the Trust response to the findings, any support required from health organisations, including the regulatory bodies and the agreed actions and next steps. Overview of review process On 6 February 2013, the Prime Minister asked Professor Sir Bruce Keogh, NHS England Medical Director, to review the quality of the care and treatment being provided by those hospital trusts in England that have been persistent outliers on mortality statistics. The 14 NHS trusts which fall within the scope of this review were selected on the basis that they have been outliers for the last two consecutive years on either the Summary Hospital Mortality Indicator (SHMI) or the Hospital Standardised Mortality Ratio 1 (HSMR) . These two measures are intended to be used in the context of this review as a ‘smoke alarm’ for identifying potential problems affecting the quality of patient care and treatment at the trusts which warrant further review. It was intended that these measures should not be reviewed in isolation and no judgements were made at the start of the review about the actual quality of care being provided to patients at the trusts.
    [Show full text]
  • 2019-20 Provider Consolidated Accounts
    Consolidated NHS provider accounts 2019 20 Health and high quality care for all, now and for future generations HC 1060 Consolidated NHS provider accounts 2019/20 1 April 2019 – 31 March 2020 Presented to Parliament under Direction of the Secretary of State for Health and Social Care pursuant to sections 7(1), 8(1), 272 and 278 of the National Health Service Act 2006 Ordered by the House of Commons to be printed 28 January 2021 HC 1060 © NHS Trust Development Authority copyright 2021 The text of this document (this excludes, where present, the Royal Arms and all departmental or agency logos) may be reproduced free of charge in any format or medium provided that it is reproduced accurately and not in a misleading context. The material must be acknowledged as NHS Trust Development Authority copyright and the document title specified. Where third party material has been identified, permission from the respective copyright holder must be sought. Any enquiries related to this publication should be sent to us at: [email protected] This publication is available at www.gov.uk/official-documents ISBN: 978-1-5286-2378-0 CCS: 1220713788 Printed on paper containing 75% recycled fibre content minimum Printed in the UK by the APS Group on behalf of the Controller of Her Majesty’s Stationery Office NHS Improvement Skipton House, 80 London Road, London SE1 6LH Telephone: 020 3747 0900 Email: [email protected] Website: https://improvement.nhs.uk/ Publication approval reference: B0403 Contents Foreword .............................................................................................. 2 Review of financial performance of NHS providers .............................. 5 Statement of accounting officer’s responsibilities and accountability framework .........................................................................................
    [Show full text]